Inventor · disambiguated record
Li Qiang
Also filed as: QIANG LI
9 granted patents·4 pending applications·11 citations·filing 2004–2025
80Inventor score
Top patents by PatentIndex Score
13 records- 0180US8067621B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2007·Granted Nov 29, 2011·5 cites·48 claims
- 0276US7598259B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2005·Granted Oct 6, 2009·2 cites·10 claims
- 0371US8569521B2Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsASBEROM THEODROS·Filed 2011·Granted Oct 29, 2013·2 cites·64 claims
- 0471US7485648B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2005·Granted Feb 3, 2009·1 cites·20 claims
- 0567US2025041330A1Method of treating obesity by selective targeting of visceral adiposity using polycation nanomedicineUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 0664US7989464B2mGluR1 antagonists as therapeutic agentsSCHERING CORP·Filed 2009·Granted Aug 2, 2011·0 cites·11 claims
- 0762US7504391B2Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2004·Granted Mar 17, 2009·1 cites·26 claims
- 0861US11826358B2Locally-induced adipose tissue browning by microneedle patch for obesity treatmentUNIV NORTH CAROLINA STATE·Filed 2018·Granted Nov 28, 2023·0 cites·19 claims
- 0957US2009082336A1mGluR1 Antagonists as Therapeutic AgentsSCHERING CORP·Filed 2008·Application pending·0 cites
- 1050US2023201128A1Method of treating obesity-induced glucose intolerance and liver fibrosisUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1150US2025255976A1Cationic biomaterials ameliorate obesity-associated chronic inflammation and focal adiposityUNIV COLUMBIA·Filed 2025·Application pending·0 cites
- 1245US7498441B2Biaryltetrahydroisoquinoline piperidines as selective MCH receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted Mar 3, 2009·0 cites·19 claims
- 1342US7361769B2Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2005·Granted Apr 22, 2008·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Li Qiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →